CN101301447B - 一种治疗癫痫的中药组合物 - Google Patents
一种治疗癫痫的中药组合物 Download PDFInfo
- Publication number
- CN101301447B CN101301447B CN2008100149330A CN200810014933A CN101301447B CN 101301447 B CN101301447 B CN 101301447B CN 2008100149330 A CN2008100149330 A CN 2008100149330A CN 200810014933 A CN200810014933 A CN 200810014933A CN 101301447 B CN101301447 B CN 101301447B
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- epilepsy
- pericarpium citri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010015037 epilepsy Diseases 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims description 16
- 239000003814 drug Substances 0.000 claims abstract description 54
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 28
- 241000522620 Scorpio Species 0.000 claims description 16
- 239000009490 scorpio Substances 0.000 claims description 16
- 241000255791 Bombyx Species 0.000 claims description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 13
- 239000004615 ingredient Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 16
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 11
- 208000026435 phlegm Diseases 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 210000002216 heart Anatomy 0.000 abstract description 9
- 230000001037 epileptic effect Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 6
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 230000002411 adverse Effects 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 244000197580 Poria cocos Species 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 244000205574 Acorus calamus Species 0.000 abstract 1
- 241000489492 Arisaema Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 235000011996 Calamus deerratus Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 abstract 1
- 235000011613 Pinus brutia Nutrition 0.000 abstract 1
- 241000018646 Pinus brutia Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 230000000474 nursing effect Effects 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 230000036461 convulsion Effects 0.000 description 16
- 206010010904 Convulsion Diseases 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 230000005856 abnormality Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229940084026 sodium valproate Drugs 0.000 description 3
- 208000014644 Brain disease Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 2
- 229960000623 carbamazepine Drugs 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229960002790 phenytoin sodium Drugs 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 2
- FJPYVLNWWICYDW-UHFFFAOYSA-M sodium;5,5-diphenylimidazolidin-1-ide-2,4-dione Chemical compound [Na+].O=C1[N-]C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 FJPYVLNWWICYDW-UHFFFAOYSA-M 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000027205 Congenital disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000034308 Grand mal convulsion Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007428 craniotomy Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WRLGYAWRGXKSKG-UHFFFAOYSA-M phenobarbital sodium Chemical compound [Na+].C=1C=CC=CC=1C1(CC)C(=O)NC([O-])=NC1=O WRLGYAWRGXKSKG-UHFFFAOYSA-M 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗癫痫的中药组合物,属中药领域。它由青皮5-15克,陈皮5-15克,莪术5-15克,菖蒲5-15克,制南星5-10克,茯神5-10克,全蝎5-10克,僵蚕5-10克,桑叶10-20克,白芍10-20克,羚羊角5-15克,钩藤5-15克,生地5-15克,茯苓5-15克,丹参5-15克配制而成。本发明能够起到清热利湿、理气化痰、调理脾肾、补益心脾的作用,且无毒副作用。该药物能够迅速、有效地缓解癫痫的症状,改善本病对患者身体、精神带来的不利影响。
Description
技术领域
本发明涉及一种中药制剂,具体为一种治疗癫痫的中药组合物。
背景技术
癫痫又俗称羊羔风,是由多种病因引起的慢性脑部疾患,是大脑神经元突发性异常放电,导致短暂的大脑功能障碍的一种慢性疾病。表现为突然发生和突然停止的意识障碍,全身抽搐、口吐白沫,全身痉挛、两眼上翻,苏醒后如常人。引起癫痫的原因繁多,常见的原因有患有中毒、缺氧、外伤、感染、脑部疾病、先天性疾病、代谢疾病、心、脑血管疾病等。
西医西药在控制癫痫发作方面有它的优势,但过强的抑制作用会使大脑神经功能受到影响,产生明显的毒副作用。如卡马西平,英纳、癫痫胺等,不但不能彻底根治癫痫,达不到治疗的目的,而且其副作用大、药物依赖性强,产生精神抑郁、智商、智力障碍等这些无法回避的副作用,因此不易被患者接受。另外,常服用抗癫痫西药,容易导致药物适应,要想保持一定的疗效就得增加剂量,形成恶性循环。我国中医中药治疗癫痫相比西药治疗更用独道之处,所以中药治疗癫痫明显优于西药。
发明内容
本发明的目的是提供一种治疗癫痫的中药组合物,该药物能够迅速、有效地缓解癫痫的症状,改善本病对患者身体、精神带来的不利影响。
本发明解决技术问题所采取的技术方案是:
该种治疗癫痫的中药组合物,其特征在于,制成药物有效成分的原料药按下述重量为:青皮5-15克,陈皮5-15克,莪术5-15克,菖蒲5-15克,制南星5-10克,茯神5-10克,全蝎5-10克,僵蚕5-10克,桑叶10-20克,白芍10-20克,羚羊角5-15克,钩藤5-15克,生地5-15克,茯苓5-15克,丹参5-15克。
本发明进一步的技术方案是:
该种治疗癫痫的中药组合物,其特征在于,制成有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术10克,菖蒲10克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地10克,茯苓10克,丹参10克。
配制及服用方法:将原料混合入砂锅内,加水适量泡透;先武火煎沸,再以文火煎半小时,滤出药液,药渣内加水适量再煎半小时,再滤出药液。两次药液混合、凉透,分别于早饭前半小时,晚饭后两小时服用。
药理作用:
1)青皮:气温,味辛。入肝、胆经。疏肝破气,散结消痰。治胸胁胃脘疼痛,疝气,食积,乳肿,乳核,久疟癖块。
2)陈皮:性温,味苦、辛。理气健脾,燥湿化痰。用于胸脘胀满、食少吐泻、咳嗽多痰。
3)莪术:苦辛,温。入肝、脾经。破血行气,消积止痛。用于血瘀腹痛、肝脾肿大、心腹胀痛,积聚,妇女血瘀经闭,跌打损伤作痛饮食积滞。
4)菖蒲:辛、温、无毒。治癫阐风疾,喉痹肿痛。食积,气积,肺损吐血,赤白带下,产后流血不止,病后耳聋,痈疸,热毒湿疮。
5)制南星:清热化痰,息风定惊。用于痰热咳嗽,咯痰黄稠,中风痰迷,癫狂惊痫。
6)茯神:甘淡,平。入心、脾经。宁心,安神,利水。治心虚惊悸,健忘,失眠,惊痫,小便不利。
7)全蝎:咸辛,平,有毒。足厥阴经。具有熄风止痉,解毒散结通络止痛之功效,能攻毒拔毒,解瘀散滞,开痰散结,破坚消肿。研究证实:全蝎具有镇静、镇痛作用。
8)僵蚕:咸、辛,平。归肝、肺、胃经。祛风定惊,化痰散结。用于惊风抽搐,咽喉肿痛,颌下淋巴结炎,面神经麻痹,皮肤瘙痒。与全蝎配药用于肝风内动引起的头痛、眩晕、抽搐。
9)桑叶:苦甘,寒。入肺、肝经。祛风清热,凉血明目。治同温发热,头痛,目赤,口渴,肺热咳嗽。
10)白芍:苦酸,凉。入肝、脾经。养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,自汗盗汗,阴虚发热。
11)羚羊角:咸,寒。入肝、心经。平肝熄风,清热镇惊,解毒。治热病神昏痉默,谵语发狂;头痛眩晕,惊痫搐搦,目赤翳膜。
12)钩藤:甘,凉。入肝、心经。清热平肝,熄风定惊。治小儿惊痫瘈疭,大人血压偏高,头晕、目眩,妇人子痫。
13)生地:苦寒清热,甘寒质润养阴,为清凉滋润之品,擅长于滋阴清热凉血。功效清热凉血,养阴生津,润肠。
14)茯苓:甘淡,平。入心、脾、肺经。渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。
15)丹参:苦,微寒;归心、肝经。活血化淤,凉血宁心。本品降而行血,善入血分,能通经脉、化淤滞、清心火、凉血热,安神志、除悸烦,常用于胸痹心痛,月经不调、疮疡肿痛,失眠及淤血肿痛等症。
本中药治疗癫痫病,治疗原则为清热利湿、理气化痰、调理脾肾、补益心脾为主,祛邪与扶正很好的有机结合,标本兼治,阴阳平衡。这样,就比西药单方面控制发作的做法要好的多。中医认为痫症之作主要由痰浊、痰聚所致,癫痫病人久发难愈,因痰浊聚散无常,以致痫发无定时,癫痫反复发作,日久不愈,导致心血不足、肾气亏虚。针对本病的病因病机,本方以全蝎、僵蚕定痫熄风;癫痫属神志疾患,火热炽盛常是其主要的诱发原因,本方以茯神、桑叶、白芍、羚羊角、钩藤、茯苓平肝泻火;以青皮、陈皮、制南星祛痰开窍;以本方以莪术、菖蒲、丹参生地破血行气、活血化瘀。诸药配伍,平降逆气,稳定脑神以控制发作,调整脏腑、经络、气血功能以巩固疗效。
本发明的有益效果是:本发明采用以上配方后,具有以下临床结果:在80例癫痫患者中,近期治愈率为83.6%,总有效率为97.2%。临床治疗观察和实验研究证明,该发明药方具有良好的镇狂、开窍、安神、键脑功能,近期痊愈率和总有效率均明显优于西药。本药以行气开郁、安神醒脑为主,能滋养大脑、镇惊息风,有效抑制癫痫病的发作,从根本上治愈癫痫顽症,治疗时间也大大缩短,一般二三个疗程即可治愈,且不易复发。
典型病例如下:
病例一,张某,男,17岁,河南人,患者两年前初次发病。发作时昏不知人、意识丧失、四肢抽搐、项背强直、口吐白沫、两目上视、呼之不应。查心、肺、肝、脾未见异常,四肢活动自如,神经系统检查未见异常,发作时间多在白天发作,无家族史。使用本中药药方治疗,治疗期间没有发作,复查脑电图轻度异常,继续用药一个月再次来院复查,脑电图未见异常,病情平稳开始减药,随访未见发作。
病例二,于某,男,7岁,山西人,癫痫病患者,发作时全身抽搐、眼睛翻白、口吐白沫、意识障碍,持续几十秒不等,严重则出现意识不清、四肢抽搐、牙关紧闭、口吐白沫、小便失禁,持续1~2分钟,缓解半小时后再次发作,每月发作数次,在当地医院服苯妥英钠、丙戊酸钠。病情不能完全控制。服用本方中药治疗两个月,其间未发作,后开始逐渐减药,今已停药半年多未见发作,复查24小时动态脑电图未见异常,患者精神状态良好,继续巩固治疗,半年后停药,回访至今没有发作。
病例三,胡明,女,35岁,河北人。患者癫痫病史13年,发作十分频繁,厉害时一天几次,每次发作口吐白沫、脸色发紫,继而抽搐,十几年来,经多方面治疗,疗效不佳。长期服用苯妥英纳、氯硝安定。病症仍未能控制。近日患者开始服用中药治疗。服用本方治疗两个月后效果很好,病情稳定,未有发作,又用药一个疗程,脑电图恢复正常,一直未发病巩固治疗壹年,停药而愈,至今未复发。
病例四,陈宇,20岁。山东人,两年前因高烧引起癫痫发作,发作时四肢抽搐、口吐白沫、牙关紧闭、目睛上视,偶有尿失禁等症状,每月发作1-2次不等,发作后头痛、乏力,数小时后恢复如常人。服用卡马西平、丙戊酸钠,症状不能完全控制,患者服用本方治疗一个月后,逐渐减去以前服用西药,一个月后发作完全控制。一年后来院复查脑电图未见异常。又继续服药半年后脑电图检查正常,终止服药,多次随访一直没有发作。
病例五,王平,男,17岁,汉族,因脑瘤开颅术后而引起癫痫大发作,发作时四肢抽搐,口吐白沫,牙关紧闭,咬破舌头。持续2-4分钟,查脑电图为异常脑电图,有尖-慢波发放。患者自发病以来,曾多次在当地以及北京等各大医院诊治,病情未见明显好转,服用本方治疗6个月后,症状控制,继续巩固治疗,半年后来复查,没有发作而且脑电图检查正常,开始减药,减药期间病情稳定,没有发作,两个月后停药,多次随访未复发。
病例六,于某,男,17岁,山东人,患者脑外伤继发癫痫7年,发作时昏不知人、身体右侧抽搐、两目瞪视、呼之不应。历时2-3分钟。发作间隔时间一般一年2-3次。服用苯巴比妥、丙戊酸钠未能有效控制症状,服用本方治疗半年,病情稳定。一直未发作,复查BEAM正常范围,巩固治疗2月后逐渐减量,2月后停药,随访至今情况良好,一切正常。
具体实施方式
例一,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术10克,菖蒲10克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地10克,茯苓10克,丹参10克。
配制及服用方法:将原料混合入砂锅内,加水适量泡透;先武火煎沸,再以文火煎半小时,滤出药液,药渣内加水适量再煎半小时,再滤出药液。两次药液混合、凉透,分别于早饭前半小时,晚饭后两小时服用。
例二,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮15克,陈皮15克,莪术10克,菖蒲10克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地10克,茯苓10克,丹参10克。配制及服用方法:同例一。
例三,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术10克,菖蒲10克,制南星8克,茯神8克,全蝎6克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地10克,茯苓10克,丹参10克。配制及服用方法:同例一。
例四,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术10克,菖蒲10克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角15克,钩藤15克,生地15克,茯苓10克,丹参10克。配制及服用方法:同例一。
例五,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术9克,菖蒲9克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地10克,茯苓10克,丹参10克。配制及服用方法:同例一。
例六,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术10克,菖蒲10克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地15克,茯苓15克,丹参15克。配制及服用方法:同例一。
例七,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮12克,陈皮12克,莪术12克,菖蒲12克,制南星10克,茯神10克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地10克,茯苓10克,丹参10克。配制及服用方法:同例一。
例八,一种治疗癫痫的中药组合物,制成药物有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术10克,菖蒲10克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶10克,白芍10克,羚羊角10克,钩藤10克,生地10克,茯苓12克,丹参12克。配制及服用方法:同例一。
Claims (2)
1.一种治疗癫痫的中药组合物,其特征在于,制成药物有效成分的原料药按下述重量为:青皮5-15克,陈皮5-15克,莪术5-15克,菖蒲5-15克,制南星5-10克,茯神5-10克,全蝎5-10克,僵蚕5-10克,桑叶10-20克,白芍10-20克,羚羊角5-15克,钩藤5-15克,生地5-15克,茯苓5-15克,丹参5-15克。
2.根据权利要求1所述的一种治疗癫痫的中药组合物,其特征在于,制成有效成分的原料药按下述重量为:青皮10克,陈皮10克,莪术10克,菖蒲10克,制南星9克,茯神9克,全蝎8克,僵蚕6克,桑叶15克,白芍15克,羚羊角10克,钩藤10克,生地10克,茯苓10克,丹参10克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100149330A CN101301447B (zh) | 2008-04-03 | 2008-04-03 | 一种治疗癫痫的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100149330A CN101301447B (zh) | 2008-04-03 | 2008-04-03 | 一种治疗癫痫的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101301447A CN101301447A (zh) | 2008-11-12 |
| CN101301447B true CN101301447B (zh) | 2010-10-06 |
Family
ID=40111664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100149330A Expired - Fee Related CN101301447B (zh) | 2008-04-03 | 2008-04-03 | 一种治疗癫痫的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101301447B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104666615A (zh) * | 2015-03-12 | 2015-06-03 | 青岛云天生物技术有限公司 | 一种治疗颤症的护理药物 |
| CN105169201A (zh) * | 2015-09-24 | 2015-12-23 | 杨立珍 | 一种医治癫痫的中药组合物及制法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087266A (zh) * | 1992-11-23 | 1994-06-01 | 高永汉 | 熄风定痫丸 |
| CN1147947A (zh) * | 1995-10-19 | 1997-04-23 | 黄吉文 | 一种治疗癫痫病的药 |
| CN1177498A (zh) * | 1997-08-27 | 1998-04-01 | 黄朝明 | 一种治疗癫痫的中药 |
| CN1191742A (zh) * | 1998-03-05 | 1998-09-02 | 马大军 | 熄痫散 |
| CN1413653A (zh) * | 2002-09-29 | 2003-04-30 | 张祖良 | 治疗心脑血管系统疾病的中药及其制备方法 |
-
2008
- 2008-04-03 CN CN2008100149330A patent/CN101301447B/zh not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087266A (zh) * | 1992-11-23 | 1994-06-01 | 高永汉 | 熄风定痫丸 |
| CN1147947A (zh) * | 1995-10-19 | 1997-04-23 | 黄吉文 | 一种治疗癫痫病的药 |
| CN1177498A (zh) * | 1997-08-27 | 1998-04-01 | 黄朝明 | 一种治疗癫痫的中药 |
| CN1191742A (zh) * | 1998-03-05 | 1998-09-02 | 马大军 | 熄痫散 |
| CN1413653A (zh) * | 2002-09-29 | 2003-04-30 | 张祖良 | 治疗心脑血管系统疾病的中药及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 王顺等.中医药治疗癫痫综述.针灸临床杂志.2007,第23卷(第12期),42-44. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101301447A (zh) | 2008-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN101301447B (zh) | 一种治疗癫痫的中药组合物 | |
| CN103251796A (zh) | 一种治疗失眠的中药 | |
| CN109999098A (zh) | 一种用于治疗肿瘤相关性睡眠障碍的中药外用制剂 | |
| CN106266638A (zh) | 一种治疗失眠的中药制剂及制备方法 | |
| CN102626503B (zh) | 一种舒心益智的中药口服液 | |
| CN104288503A (zh) | 一种益气补肾的中药酒 | |
| CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
| CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
| CN103768408A (zh) | 一种防治肛肠疾病术后疼痛的药物 | |
| CN103830666B (zh) | 一种治疗高血压的中药足浴组合物 | |
| CN107137649A (zh) | 一种治疗女性尿道综合征的中药冲剂及制备方法 | |
| CN105233075A (zh) | 一种治疗冠心病的中药组合物 | |
| CN104784588A (zh) | 一种用于治疗神经性头痛的中药制剂及制备方法 | |
| CN102626504A (zh) | 一种防治抑郁症的中药口服液 | |
| CN105343794A (zh) | 一种治疗神经衰弱的药物及其制备方法 | |
| CN105232159A (zh) | 一种防治高血压的套盒 | |
| CN105363016A (zh) | 用于治疗头痛的药物 | |
| CN105213937A (zh) | 一种治疗心脏神经官能症的中药 | |
| CN102178917B (zh) | 一种治疗气机乱窜的中药组合物 | |
| CN104474515A (zh) | 一种治疗精神分裂症的中药组合物 | |
| CN104096112A (zh) | 一种治疗冠心病心绞痛的中药组合物 | |
| CN103893496A (zh) | 一种治疗心绞痛的中药制剂及制备方法 | |
| CN104306943A (zh) | 一种治疗高血脂症的中药组合物 | |
| CN104491537A (zh) | 一种治疗风湿性心脏病的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101006 Termination date: 20110403 |